Key result
Rare variants in non-GWAS candidate genes were more frequent in patients with polygenic adult-onset hypertriglyceridemia compared to controls.
Why the study?
Do rare variants in non-GWAS candidate genes accumulate more frequently in patients with polygenic adult-onset hypertriglyceridemia compared to controls?
Case-Control (n=737)
Do rare variants in non-GWAS candidate genes accumulate more frequently in patients with polygenic adult-onset hypertriglyceridemia compared to controls?
Rare genetic variants in non-GWAS candidate genes (especially LMF1, APOC2, and CREB3L3) are significantly enriched in patients with polygenic adult-onset hypertriglyceridemia.
Answers are grounded in this paper and cite their sources.
Should not yet change management; extends candidate gene evidence but remains hypothesis-generating.
BACKGROUND: Rare variant accumulation studies can implicate genes in disease susceptibility when a significant burden is observed in patients versus control subjects. Such analyses might be particularly useful for candidate genes that are selected based on experiments other than genome-wide association studies (GWAS). We sought to determine whether rare variants in non-GWAS candidate genes identified from mouse models and human mendelian syndromes of hypertriglyceridemia (HTG) accumulate in patients with polygenic adult-onset HTG. METHODS AND RESULTS: We resequenced protein coding regions of 3 genes with established roles (APOC2, GPIHBP1, LMF1) and 2 genes recently implicated (CREB3L3 and ZHX3) in TG metabolism. We identified 41 distinct heterozygous rare variants, including 29 singleton variants, in the combined sample; in total, we observed 47 rare variants in 413 HTG patients versus 16 in 324 control subjects (odds ratio=2.3; P=0.0050). Post hoc assessment of genetic burden in individual genes using 3 different tests suggested that the genetic burden was most prominent in the established genes LMF1 and APOC2, and also in the recently identified CREB3L3 gene. CONCLUSIONS: These extensive resequencing studies show a significant accumulation of rare genetic variants in non-GWAS candidate genes among patients with polygenic HTG, and indicate the importance of testing specific hypotheses in large-scale resequencing studies.
No takes yet. Share an insight, caveat, or question.
Johansen et al. (2011) conducted a case-control in Hypertriglyceridemia (n=737). Rare variants in non-GWAS candidate genes vs. Control subjects was evaluated on Accumulation of rare variants in 5 candidate genes (APOC2, GPIHBP1, LMF1, CREB3L3, ZHX3) (OR 2.3, p=0.0050). Rare variants in non-GWAS candidate genes were more frequent in patients with polygenic adult-onset hypertriglyceridemia compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: